US Stock MarketDetailed Quotes
CAH Cardinal Health
- 116.220
- +0.310+0.27%
Trading Dec 19 10:45 ET
28.13BMarket Cap22.35P/E (TTM)
116.533High114.998Low232.18KVolume115.440Open115.910Pre Close26.87MTurnover0.10%Turnover Ratio33.69P/E (Static)242.01MShares126.23052wk High-8.58P/B27.98BFloat Cap92.74352wk Low2.01Dividend TTM240.78MShs Float126.230Historical High1.73%Div YieldTTM1.32%Amplitude14.535Historical Low115.725Avg Price1Lot Size
Cardinal Health Key Stats
Quarterly+Annual
YOY
| (Q1)Sep 30, 2024 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | (Q1)Sep 30, 2023 | (FY)Jun 30, 2023 | (Q4)Jun 30, 2023 | (Q3)Mar 31, 2023 | (Q2)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -411.93%-1.65B | 32.28%3.76B | 140.67%2.08B | -103.60%-49M | 102.01%1.21B | 2,195.65%528M | -10.43%2.84B | -71.66%863M | 424.82%1.36B | -50.04%597M |
| Net income from continuing operations | 3,890.91%417M | 157.70%853M | 7,700.00%234M | -25.36%259M | 385.38%371M | -109.91%-11M | 135.33%331M | -97.73%3M | 124.96%347M | -365.31%-130M |
| Depreciation and amortization | 5.81%182M | 2.60%710M | 5.68%186M | 1.14%177M | 2.94%175M | 0.58%172M | 0.00%692M | -1.68%176M | -3.31%175M | 3.66%170M |
| Deferred tax | ---- | -160.00%-104M | ---- | ---- | ---- | ---- | -385.71%-40M | ---- | ---- | ---- |
| Change In working capital | -981.13%-2.29B | 230.42%1.51B | 394.87%1.74B | -179.18%-616M | 388.94%601M | 54.31%-212M | -62.23%457M | -85.44%351M | 184.98%778M | 39.36%-208M |
| -Change in receivables | 396.55%288M | -4.84%-996M | -66.82%-734M | -44.99%225M | -32.60%-545M | 111.42%58M | 32.38%-950M | -107.55%-440M | 147.34%409M | -257.39%-411M |
| -Change in inventory | 36.81%-678M | 370.63%1.12B | 314.33%2.49B | 84.63%1.17B | -6.09%-1.46B | -306.44%-1.07B | 65.78%-412M | 312.77%600M | 212.48%631M | -494.40%-1.38B |
| -Change in payables and accrued expense | -336.86%-1.9B | -23.53%1.39B | -107.85%-15M | -665.65%-2.01B | 64.92%2.61B | 160.71%803M | -52.37%1.82B | -93.42%191M | -115.43%-262M | 39,450.00%1.58B |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -411.93%-1.65B | 32.28%3.76B | 140.67%2.08B | -103.60%-49M | 102.01%1.21B | 2,195.65%528M | -10.43%2.84B | -71.66%863M | 424.82%1.36B | -50.04%597M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -39.68%-88M | -307.27%-1.85B | 180.58%166M | -1,929.67%-1.85B | -20.69%-105M | 10.00%-63M | -180.07%-454M | -0.98%-206M | -106.82%-91M | -85.11%-87M |
| Net PPE purchase and sale | 1.10%-90M | -6.40%-499M | 7.73%-191M | 4.59%-104M | -32.94%-113M | -33.82%-91M | -31.74%-469M | -43.75%-207M | 89.20%-109M | -109.84%-85M |
| Net business purchase and sale | --2M | -11,710.00%-1.18B | --2M | -11,820.00%-1.19B | --9M | --0 | -101.11%-10M | --0 | -101.08%-10M | ---- |
| Net investment purchase and sale | --0 | -776.00%-169M | 35,400.00%355M | -2,067.86%-551M | 50.00%-1M | 1,500.00%28M | 13.64%25M | 102.63%1M | -33.33%28M | -112.50%-2M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -39.68%-88M | -307.27%-1.85B | 180.58%166M | -1,929.67%-1.85B | -20.69%-105M | 10.00%-63M | -180.07%-454M | -0.98%-206M | -106.82%-91M | -85.11%-87M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 18.92%-540M | 72.24%-847M | -45.10%-859M | 210.39%1.03B | 2.49%-353M | 42.73%-666M | -23.87%-3.05B | -42.65%-592M | -174.71%-934M | 18.47%-362M |
| Net issuance payments of debt | -28.57%-9M | 161.49%356M | -9,400.00%-760M | 302.69%1.13B | -33.33%-8M | 0.00%-7M | 34.58%-579M | 97.22%-8M | -11,060.00%-558M | -20.00%-6M |
| Net common stock issuance | 25.00%-375M | 62.50%-750M | --0 | --0 | 0.00%-250M | 50.00%-500M | -100.00%-2B | ---500M | -25.00%-250M | 16.67%-250M |
| Cash dividends paid | 2.29%-128M | 4.95%-499M | 3.17%-122M | 4.69%-122M | 3.88%-124M | 7.75%-131M | 6.08%-525M | 5.97%-126M | 5.88%-128M | 7.86%-129M |
| Net other financing activities | 0.00%-28M | -13.21%46M | -45.24%23M | 1,000.00%22M | 26.09%29M | -100.00%-28M | 378.95%53M | 500.00%42M | 100.00%2M | 2,200.00%23M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 18.92%-540M | 72.24%-847M | -45.10%-859M | 210.39%1.03B | 2.49%-353M | 42.73%-666M | -23.87%-3.05B | -42.65%-592M | -174.71%-934M | 18.47%-362M |
| Net cash flow | ||||||||||
| Beginning cash position | 25.93%5.13B | -14.10%4.08B | -6.82%3.72B | 25.64%4.59B | 10.82%3.87B | -13.59%4.08B | 40.30%4.75B | 69.35%3.99B | 15.60%3.65B | 41.78%3.49B |
| Current changes in cash | -1,031.84%-2.28B | 261.27%1.07B | 2,029.23%1.38B | -357.44%-865M | 405.41%748M | 83.39%-201M | -151.68%-661M | -97.32%65M | 141.84%336M | -78.98%148M |
| Effect of exchange rate changes | 280.00%9M | -12.50%-9M | 71.43%-2M | ---8M | -57.14%6M | 66.67%-5M | 68.00%-8M | 41.67%-7M | --0 | 333.33%14M |
| End cash Position | -25.92%2.87B | 25.93%5.13B | 25.93%5.13B | -6.82%3.72B | 25.64%4.59B | 10.82%3.87B | -14.10%4.08B | -14.10%4.08B | 69.35%3.99B | 15.60%3.65B |
| Free cash flow | -498.39%-1.74B | 37.58%3.25B | 191.64%1.88B | -112.86%-161M | 113.28%1.09B | 1,027.66%436M | -15.24%2.36B | -77.58%646M | 349.90%1.25B | -54.33%512M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- | -- |
Heat List
US
Overall
Symbol
Price
% Chg
No Data